Activation of GABA A receptors by taurine and muscimol blocks the neurotoxicity of β-amyloid in rat hippocampal and cortical neurons
The β-amyloid peptide (Aβ) is centrally related to the pathogenesis of Alzheimer's disease (AD) and is potently neurotoxic to central nervous system neurons. The neurotoxicity of Aβ has been partially related to the over activation of glutamatergic transmission and excitotoxicity. Taurine is a...
Gespeichert in:
Veröffentlicht in: | Neuropharmacology 2005-12, Vol.49 (8), p.1140-1148 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1148 |
---|---|
container_issue | 8 |
container_start_page | 1140 |
container_title | Neuropharmacology |
container_volume | 49 |
creator | Paula-Lima, Andréa C. De Felice, Fernanda G. Brito-Moreira, Jordano Ferreira, Sérgio T. |
description | The β-amyloid peptide (Aβ) is centrally related to the pathogenesis of Alzheimer's disease (AD) and is potently neurotoxic to central nervous system neurons. The neurotoxicity of Aβ has been partially related to the over activation of glutamatergic transmission and excitotoxicity. Taurine is a naturally occurring β-amino acid present in the mammalian brain. Due to its safety and tolerability, taurine has been clinically used in humans in the treatment of a number of non-neurological disorders. Here, we show that micromolar doses of taurine block the neurotoxicity of Aβ to rat hippocampal and cortical neurons in culture. Moreover, taurine also rescues central neurons from the excitotoxicity induced by high concentrations of extracellular glutamate. Neuroprotection by taurine is abrogated by picrotoxin, a GABA
A receptor antagonist. GABA and muscimol, an agonist of the GABA
A receptor, also block neuronal death induced by Aβ in rat hippocampal and cortical neurons. These results suggest that activation of GABA
A receptors protects neurons against Aβ toxicity in AD-affected regions of the mammalian brain and that taurine should be investigated as a novel therapeutic tool in the treatment of AD and of other neurological disorders in which excitotoxicity plays a relevant role. |
doi_str_mv | 10.1016/j.neuropharm.2005.06.015 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_elsev</sourceid><recordid>TN_cdi_pubmed_primary_16150468</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0028390805002339</els_id><sourcerecordid>16150468</sourcerecordid><originalsourceid>FETCH-LOGICAL-e198t-8da5d8f8cf1adf2e75c66804fbf4a67aeac1c4dd43400dc680037f9491870af3</originalsourceid><addsrcrecordid>eNpFkU1OwzAQhS0EoqVwBeQLJIwbx3GWaQUFCYlN95brH9UliSPHrcgBuBAH4UykLYjVaDRvnmbehxAmkBIg7GGXtmYffLeVoUnnAHkKLAWSX6Ap4UWWFMDoJZoCzHmSlcAn6KbvdwBAOeHXaEIYyYEyPkWflYruIKPzLfYWr6pFhSscjDJd9KHHmwFHuQ-uNVi2Gjf7XrnG13hTe_Xe47g1-HRK9B9OuTgcTb6_EtkMtXcauxYHGfHWdZ1XsulkfbJRPkSnxua02_a36MrKujd3v3WG1k-P6-Vz8vq2ellWr4khJY8J1zLX3HJlidR2bopcMcaB2o2lkhXSSEUU1ZpmFECrcQRZYUtajqGAtNkM3Z9tu_2mMVp0wTUyDOIvjlGwOAvMeMTBmSDGd02rjHZjJFFo7wQBcWQgduKfgTgyEMDEyCD7AWbWgEs</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Activation of GABA A receptors by taurine and muscimol blocks the neurotoxicity of β-amyloid in rat hippocampal and cortical neurons</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Paula-Lima, Andréa C. ; De Felice, Fernanda G. ; Brito-Moreira, Jordano ; Ferreira, Sérgio T.</creator><creatorcontrib>Paula-Lima, Andréa C. ; De Felice, Fernanda G. ; Brito-Moreira, Jordano ; Ferreira, Sérgio T.</creatorcontrib><description>The β-amyloid peptide (Aβ) is centrally related to the pathogenesis of Alzheimer's disease (AD) and is potently neurotoxic to central nervous system neurons. The neurotoxicity of Aβ has been partially related to the over activation of glutamatergic transmission and excitotoxicity. Taurine is a naturally occurring β-amino acid present in the mammalian brain. Due to its safety and tolerability, taurine has been clinically used in humans in the treatment of a number of non-neurological disorders. Here, we show that micromolar doses of taurine block the neurotoxicity of Aβ to rat hippocampal and cortical neurons in culture. Moreover, taurine also rescues central neurons from the excitotoxicity induced by high concentrations of extracellular glutamate. Neuroprotection by taurine is abrogated by picrotoxin, a GABA
A receptor antagonist. GABA and muscimol, an agonist of the GABA
A receptor, also block neuronal death induced by Aβ in rat hippocampal and cortical neurons. These results suggest that activation of GABA
A receptors protects neurons against Aβ toxicity in AD-affected regions of the mammalian brain and that taurine should be investigated as a novel therapeutic tool in the treatment of AD and of other neurological disorders in which excitotoxicity plays a relevant role.</description><identifier>ISSN: 0028-3908</identifier><identifier>EISSN: 1873-7064</identifier><identifier>DOI: 10.1016/j.neuropharm.2005.06.015</identifier><identifier>PMID: 16150468</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Amyloid beta-Peptides - antagonists & inhibitors ; Amyloid beta-Peptides - toxicity ; Animals ; Cell Survival ; Cells, Cultured ; Cerebral Cortex - cytology ; Cerebral Cortex - drug effects ; Cortical neurons ; GABA A receptor ; GABA Agonists - pharmacology ; GABA-A Receptor Agonists ; Hippocampal neurons ; Hippocampus - drug effects ; Muscimol ; Muscimol - pharmacology ; Neurons - drug effects ; Neurotoxicity ; Rats ; Rats, Sprague-Dawley ; Taurine ; Taurine - pharmacology ; β-Amyloid peptide</subject><ispartof>Neuropharmacology, 2005-12, Vol.49 (8), p.1140-1148</ispartof><rights>2005 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.neuropharm.2005.06.015$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,782,786,3554,27933,27934,46004</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16150468$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Paula-Lima, Andréa C.</creatorcontrib><creatorcontrib>De Felice, Fernanda G.</creatorcontrib><creatorcontrib>Brito-Moreira, Jordano</creatorcontrib><creatorcontrib>Ferreira, Sérgio T.</creatorcontrib><title>Activation of GABA A receptors by taurine and muscimol blocks the neurotoxicity of β-amyloid in rat hippocampal and cortical neurons</title><title>Neuropharmacology</title><addtitle>Neuropharmacology</addtitle><description>The β-amyloid peptide (Aβ) is centrally related to the pathogenesis of Alzheimer's disease (AD) and is potently neurotoxic to central nervous system neurons. The neurotoxicity of Aβ has been partially related to the over activation of glutamatergic transmission and excitotoxicity. Taurine is a naturally occurring β-amino acid present in the mammalian brain. Due to its safety and tolerability, taurine has been clinically used in humans in the treatment of a number of non-neurological disorders. Here, we show that micromolar doses of taurine block the neurotoxicity of Aβ to rat hippocampal and cortical neurons in culture. Moreover, taurine also rescues central neurons from the excitotoxicity induced by high concentrations of extracellular glutamate. Neuroprotection by taurine is abrogated by picrotoxin, a GABA
A receptor antagonist. GABA and muscimol, an agonist of the GABA
A receptor, also block neuronal death induced by Aβ in rat hippocampal and cortical neurons. These results suggest that activation of GABA
A receptors protects neurons against Aβ toxicity in AD-affected regions of the mammalian brain and that taurine should be investigated as a novel therapeutic tool in the treatment of AD and of other neurological disorders in which excitotoxicity plays a relevant role.</description><subject>Amyloid beta-Peptides - antagonists & inhibitors</subject><subject>Amyloid beta-Peptides - toxicity</subject><subject>Animals</subject><subject>Cell Survival</subject><subject>Cells, Cultured</subject><subject>Cerebral Cortex - cytology</subject><subject>Cerebral Cortex - drug effects</subject><subject>Cortical neurons</subject><subject>GABA A receptor</subject><subject>GABA Agonists - pharmacology</subject><subject>GABA-A Receptor Agonists</subject><subject>Hippocampal neurons</subject><subject>Hippocampus - drug effects</subject><subject>Muscimol</subject><subject>Muscimol - pharmacology</subject><subject>Neurons - drug effects</subject><subject>Neurotoxicity</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Taurine</subject><subject>Taurine - pharmacology</subject><subject>β-Amyloid peptide</subject><issn>0028-3908</issn><issn>1873-7064</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkU1OwzAQhS0EoqVwBeQLJIwbx3GWaQUFCYlN95brH9UliSPHrcgBuBAH4UykLYjVaDRvnmbehxAmkBIg7GGXtmYffLeVoUnnAHkKLAWSX6Ap4UWWFMDoJZoCzHmSlcAn6KbvdwBAOeHXaEIYyYEyPkWflYruIKPzLfYWr6pFhSscjDJd9KHHmwFHuQ-uNVi2Gjf7XrnG13hTe_Xe47g1-HRK9B9OuTgcTb6_EtkMtXcauxYHGfHWdZ1XsulkfbJRPkSnxua02_a36MrKujd3v3WG1k-P6-Vz8vq2ellWr4khJY8J1zLX3HJlidR2bopcMcaB2o2lkhXSSEUU1ZpmFECrcQRZYUtajqGAtNkM3Z9tu_2mMVp0wTUyDOIvjlGwOAvMeMTBmSDGd02rjHZjJFFo7wQBcWQgduKfgTgyEMDEyCD7AWbWgEs</recordid><startdate>20051201</startdate><enddate>20051201</enddate><creator>Paula-Lima, Andréa C.</creator><creator>De Felice, Fernanda G.</creator><creator>Brito-Moreira, Jordano</creator><creator>Ferreira, Sérgio T.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20051201</creationdate><title>Activation of GABA A receptors by taurine and muscimol blocks the neurotoxicity of β-amyloid in rat hippocampal and cortical neurons</title><author>Paula-Lima, Andréa C. ; De Felice, Fernanda G. ; Brito-Moreira, Jordano ; Ferreira, Sérgio T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e198t-8da5d8f8cf1adf2e75c66804fbf4a67aeac1c4dd43400dc680037f9491870af3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Amyloid beta-Peptides - antagonists & inhibitors</topic><topic>Amyloid beta-Peptides - toxicity</topic><topic>Animals</topic><topic>Cell Survival</topic><topic>Cells, Cultured</topic><topic>Cerebral Cortex - cytology</topic><topic>Cerebral Cortex - drug effects</topic><topic>Cortical neurons</topic><topic>GABA A receptor</topic><topic>GABA Agonists - pharmacology</topic><topic>GABA-A Receptor Agonists</topic><topic>Hippocampal neurons</topic><topic>Hippocampus - drug effects</topic><topic>Muscimol</topic><topic>Muscimol - pharmacology</topic><topic>Neurons - drug effects</topic><topic>Neurotoxicity</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Taurine</topic><topic>Taurine - pharmacology</topic><topic>β-Amyloid peptide</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Paula-Lima, Andréa C.</creatorcontrib><creatorcontrib>De Felice, Fernanda G.</creatorcontrib><creatorcontrib>Brito-Moreira, Jordano</creatorcontrib><creatorcontrib>Ferreira, Sérgio T.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Neuropharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Paula-Lima, Andréa C.</au><au>De Felice, Fernanda G.</au><au>Brito-Moreira, Jordano</au><au>Ferreira, Sérgio T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Activation of GABA A receptors by taurine and muscimol blocks the neurotoxicity of β-amyloid in rat hippocampal and cortical neurons</atitle><jtitle>Neuropharmacology</jtitle><addtitle>Neuropharmacology</addtitle><date>2005-12-01</date><risdate>2005</risdate><volume>49</volume><issue>8</issue><spage>1140</spage><epage>1148</epage><pages>1140-1148</pages><issn>0028-3908</issn><eissn>1873-7064</eissn><abstract>The β-amyloid peptide (Aβ) is centrally related to the pathogenesis of Alzheimer's disease (AD) and is potently neurotoxic to central nervous system neurons. The neurotoxicity of Aβ has been partially related to the over activation of glutamatergic transmission and excitotoxicity. Taurine is a naturally occurring β-amino acid present in the mammalian brain. Due to its safety and tolerability, taurine has been clinically used in humans in the treatment of a number of non-neurological disorders. Here, we show that micromolar doses of taurine block the neurotoxicity of Aβ to rat hippocampal and cortical neurons in culture. Moreover, taurine also rescues central neurons from the excitotoxicity induced by high concentrations of extracellular glutamate. Neuroprotection by taurine is abrogated by picrotoxin, a GABA
A receptor antagonist. GABA and muscimol, an agonist of the GABA
A receptor, also block neuronal death induced by Aβ in rat hippocampal and cortical neurons. These results suggest that activation of GABA
A receptors protects neurons against Aβ toxicity in AD-affected regions of the mammalian brain and that taurine should be investigated as a novel therapeutic tool in the treatment of AD and of other neurological disorders in which excitotoxicity plays a relevant role.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>16150468</pmid><doi>10.1016/j.neuropharm.2005.06.015</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0028-3908 |
ispartof | Neuropharmacology, 2005-12, Vol.49 (8), p.1140-1148 |
issn | 0028-3908 1873-7064 |
language | eng |
recordid | cdi_pubmed_primary_16150468 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Amyloid beta-Peptides - antagonists & inhibitors Amyloid beta-Peptides - toxicity Animals Cell Survival Cells, Cultured Cerebral Cortex - cytology Cerebral Cortex - drug effects Cortical neurons GABA A receptor GABA Agonists - pharmacology GABA-A Receptor Agonists Hippocampal neurons Hippocampus - drug effects Muscimol Muscimol - pharmacology Neurons - drug effects Neurotoxicity Rats Rats, Sprague-Dawley Taurine Taurine - pharmacology β-Amyloid peptide |
title | Activation of GABA A receptors by taurine and muscimol blocks the neurotoxicity of β-amyloid in rat hippocampal and cortical neurons |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T09%3A46%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_elsev&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Activation%20of%20GABA%20A%20receptors%20by%20taurine%20and%20muscimol%20blocks%20the%20neurotoxicity%20of%20%CE%B2-amyloid%20in%20rat%20hippocampal%20and%20cortical%20neurons&rft.jtitle=Neuropharmacology&rft.au=Paula-Lima,%20Andr%C3%A9a%20C.&rft.date=2005-12-01&rft.volume=49&rft.issue=8&rft.spage=1140&rft.epage=1148&rft.pages=1140-1148&rft.issn=0028-3908&rft.eissn=1873-7064&rft_id=info:doi/10.1016/j.neuropharm.2005.06.015&rft_dat=%3Cpubmed_elsev%3E16150468%3C/pubmed_elsev%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/16150468&rft_els_id=S0028390805002339&rfr_iscdi=true |